X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Dr. Reddys Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Quarterly Results   (REDY)

Here are the latest quarterly results of Dr. Reddys. For more details, see the Dr. Reddys financial fact sheet and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dr. Reddys Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m32,22536,16337,23236,11933,33235,59838,34135,539 
Other income Rs m670438403205380316430449 
Turnover Rs m32,89536,60137,63536,32433,71235,91438,77135,988 
Expenses Rs m28,32329,89328,58730,21430,10028,90430,41429,903 
Gross profit Rs m3,9756,3558,7346,0073,3306,7867,9275,705 
Depreciation Rs m2,4362,6222,6652,5432,5922,7022,7152,763 
Interest Rs m148126164196215223172178 
Profit before tax Rs m2,0614,0456,3083,4739034,1775,4703,213 
Tax Rs m5269561,385972371,1232,528492 
Profit after tax Rs m1,5353,0894,9233,3766663,0542,9422,721 
Gross profit margin %12.317.623.516.610.019.120.716.1 
Effective tax rate %25.523.622.02.826.226.946.215.3 
Net profit margin %4.88.513.29.32.08.67.77.7 
Diluted EPS Rs 9.3 18.6 29.7 20.4 4.0 18.4 17.8 16.4  
Diluted EPS (TTM) Rs 90.4 67.7 62.1 78.0 72.7 72.5 60.6 56.6  
 Subscriber Feature View       View View View    
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   DISHMAN PHARMA  BIOCON LTD  WOCKHARDT LTD.  FULFORD INDIA  AUROBINDO PHARMA  

Compare DR. REDDYS LAB With:   DISHMAN PHARMA  BIOCON LTD  WOCKHARDT LTD.  FULFORD INDIA  AUROBINDO PHARMA  

Compare DR. REDDYS LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Depreciating Rupee, Rising Fuel Prices, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed on a negative note yesterday. Sectoral indices traded on a mixed note, with stocks in the metal sector and stocks in the oil and gas sector, leading the losses.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


May 23, 2018 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - FULFORD INDIA COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS